Incysus Therapeutics Inc. announced the appointment of Rozanna Yaing as Senior Vice President, Quality and Regulatory Affairs, effective July 1, 2019. Ms. Yaing will be responsible for quality and regulatory affairs across Incysus’ portfolio and will serve on the Company’s Executive Committee. She joins Incysus from AxoGen Corporation, where she was Vice President of Quality. In that position, Ms. Yaing established quality and compliance strategies to realize sustainable growth and achieve BLA approval. Earlier in her career, Ms. Yaing held significant senior positions in Quality at Unum Therapeutics Inc., uniQure Inc., and Biocompass Inc.